<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02981264</url>
  </required_header>
  <id_info>
    <org_study_id>Transcricoid EBUS RCT</org_study_id>
    <nct_id>NCT02981264</nct_id>
  </id_info>
  <brief_title>Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During EBUS-TBNA</brief_title>
  <acronym>CRISPEN</acronym>
  <official_title>Transcricoid Injection vs. Spray as You go Method for Local Anaesthesia During Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>All India Institute of Medical Sciences, New Delhi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>All India Institute of Medical Sciences, New Delhi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Endobronchial Ultrasound Guided Transbronchial Needle Aspiration (EBUS -TBNA) is commonly&#xD;
      performed for diagnosis of mediastinal pathologies. The procedure can either be performed&#xD;
      under general anaesthesia or under moderate sedation with topical anaesthesia. Most patients&#xD;
      tolerate the procedure well although cough is often reported as a distressing symptom.&#xD;
      Topical lignocaine is administered during endobronchial ultrasound for local anaesthesia.&#xD;
      There is limited literature on the efficacy of transtracheal/transcricoid injection versus&#xD;
      spray as you go method for lignocaine delivery to the airways during EBUS-TBNA. This study&#xD;
      would help to determine the procedure comfort for the patient while using the&#xD;
      transtracheal/transcricoid method vs the spray as you go method.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For all patients meeting the inclusion criteria, the demographic profile including age, sex,&#xD;
      weight, smoking history shall be recorded. A written informed consent will be obtained from&#xD;
      all participants. The patients who undergo EBUS-TBNA under moderate sedation would be&#xD;
      randomised in a one is to one ratio either to transcricoid injection or spray as you go&#xD;
      lignocaine group. Prior to EBUS-TBNA, Blood pressure, pulse rate, respiratory rate and pulse&#xD;
      oximetry saturation will be recorded at the baseline Patients in both the groups shall be&#xD;
      prepared in a similar fashion except for the use of transcricoid injection in one group.&#xD;
&#xD;
      During the procedure, 2 ml aliquots of 1% lignocaine solution will be delivered through the&#xD;
      bronchoscope when using spray-as-you go technique. Patients in the transcricoid group shall&#xD;
      initially receive 5 ml of 2% lignocaine solution and additional aliquots of 1% lignocaine&#xD;
      using the spray as you go method. The total lignocaine dose during the procedure will be&#xD;
      recorded. The patients would be monitored for any adverse effects throughout the procedure.&#xD;
      The bronchoscopist doing the procedure will be provided VAS charts to mark the severity of&#xD;
      cough and overall procedure satisfaction. An audio recorder shall be used to record the cough&#xD;
      count during the entire procedure.&#xD;
&#xD;
      Post procedure, patients will record the pain experienced while undergoing the procedure on&#xD;
      the VAS scale.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">January 2019</completion_date>
  <primary_completion_date type="Actual">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall cough count</measure>
    <time_frame>At study completion approximately 12 months</time_frame>
    <description>Cough count till reaching carina</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Operator rated overall procedure satisfaction</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
    <description>Operator rated satisfaction on VAS scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time from scope insertion to crossing the vocal cords</measure>
    <time_frame>At study completion approximately 12 months</time_frame>
    <description>Time in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall procedure duration</measure>
    <time_frame>At study completion approximately 12 months</time_frame>
    <description>Time in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Lignocaine dose</measure>
    <time_frame>At study completion approximately 12 months</time_frame>
    <description>Total dose of lignocaine in milligrams</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">365</enrollment>
  <condition>Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Transcricoid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lignocaine delivery using transcricoid injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spray as You go</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lignocaine delivery using spray as you go method</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Transcricoid Injection</intervention_name>
    <arm_group_label>Transcricoid</arm_group_label>
    <other_name>Lignocaine delivered through the cricothyroid membrane</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Spray as you go</intervention_name>
    <arm_group_label>Spray as You go</arm_group_label>
    <other_name>Lignocaine delivered through the bronchoscope working channel.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Indication for EBUS TBNA&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal of consent&#xD;
&#xD;
          -  Known documented hypersensitivity to lignocaine&#xD;
&#xD;
          -  Procedure performed under general anaesthesia&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Hypoxemia (oxygen saturation [by pulse oximetry] &lt; 92% with Fio2 of â‰¥ 0.3&#xD;
&#xD;
          -  Bronchoscopy done through endotracheal or tracheostomy tube&#xD;
&#xD;
          -  Midline neck mass or thyroid enlargement making the identification of&#xD;
&#xD;
          -  cricothyroid membrane difficult'&#xD;
&#xD;
          -  Patients with central airway obstruction&#xD;
&#xD;
          -  Patients with active ongoing hemoptysis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randeep Guleria, MD, DM</last_name>
    <role>Study Chair</role>
    <affiliation>All India Institute of Medical Sciences, New Delhi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AIIMS</name>
      <address>
        <city>New Delhi</city>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>December 1, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2016</study_first_posted>
  <last_update_submitted>November 25, 2020</last_update_submitted>
  <last_update_submitted_qc>November 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>All India Institute of Medical Sciences, New Delhi</investigator_affiliation>
    <investigator_full_name>Karan Madan</investigator_full_name>
    <investigator_title>Dr. Karan Madan, MD, DM Assistant Professor, Pulmonary Medicine and Sleep Disorders</investigator_title>
  </responsible_party>
  <keyword>Bronchoscopy</keyword>
  <keyword>Lignocaine</keyword>
  <keyword>Endobronchial Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data on demographics and outcomes shall be available on reasonable request</ipd_description>
    <ipd_time_frame>For two years since the study completion</ipd_time_frame>
    <ipd_access_criteria>Available on reasonable request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

